Apo-Clobazam · DIN 02244638 · 10mg · tablet
Limited Use — Reason for Use code 23 requiredMarketed · checked 2026-09-20
StatusLimited Use — Reason for Use code 23 required
Write on scriptLU code 23 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 23
Reason for Use code 23
As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.
Coverage limit:
Because a large number of patients will become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Apo-Clobazam · DIN 02244638
Manufacturer: Apotex Inc.; listing date 2003-01-30
Health Canada: Marketed since 2001-11-28 · brand APO-CLOBAZAM · ATC N05BA09 CLOBAZAM · form Tablet · route Oral · ingredients CLOBAZAM 10 MG · company Apotex inc · schedule Targeted substances (cdsa iv)
Apo-Clobazam: Formulary list price $0.2197/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.2197 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=68625 · Verify on the e-Formulary ↗ (DIN 02244638)
Source record
DIN 02244638: Apo-Clobazam
Raw flags: sec12=Y, sec3=Y
Item: 281200061; group id 425; item number 1058; lccId 00071; manufacturer id APX
Source form: Tab; strength: 10mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.2197; ministry $0.2197
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02244638
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=68625
Interchangeable products
Frisium · DIN 02221799 · not recorded
Teva-Clobazam · DIN 02238334 · $0.2197
Shortage status: not checked (no credentials)